rs117481449

Variant summary

Our verdict is Benign. The variant received -19 ACMG points: 0P and 19B. BP4_ModerateBP6_Very_StrongBP7BS1BS2

The NM_014918.5(CHSY1):​c.333G>A​(p.Lys111Lys) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00541 in 1,610,168 control chromosomes in the GnomAD database, including 94 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0054 ( 8 hom., cov: 32)
Exomes 𝑓: 0.0054 ( 86 hom. )

Consequence

CHSY1
NM_014918.5 synonymous

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: 0.854

Publications

1 publications found
Variant links:
Genes affected
CHSY1 (HGNC:17198): (chondroitin sulfate synthase 1) This gene encodes a member of the chondroitin N-acetylgalactosaminyltransferase family. These enzymes possess dual glucuronyltransferase and galactosaminyltransferase activity and play critical roles in the biosynthesis of chondroitin sulfate, a glycosaminoglycan involved in many biological processes including cell proliferation and morphogenesis. Decreased expression of this gene may play a role in colorectal cancer, and mutations in this gene are a cause of temtamy preaxial brachydactyly syndrome. [provided by RefSeq, Dec 2011]
CHSY1 Gene-Disease associations (from GenCC):
  • temtamy preaxial brachydactyly syndrome
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, Labcorp Genetics (formerly Invitae), Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -19 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.39).
BP6
Variant 15-101235565-C-T is Benign according to our data. Variant chr15-101235565-C-T is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 534523.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.854 with no splicing effect.
BS1
Variant frequency is greater than expected in population amr. GnomAd4 allele frequency = 0.0054 (822/152160) while in subpopulation AMR AF = 0.0293 (447/15266). AF 95% confidence interval is 0.027. There are 8 homozygotes in GnomAd4. There are 420 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 8 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CHSY1NM_014918.5 linkc.333G>A p.Lys111Lys synonymous_variant Exon 2 of 3 ENST00000254190.4 NP_055733.2 Q86X52
CHSY1XM_011521364.3 linkc.333G>A p.Lys111Lys synonymous_variant Exon 2 of 4 XP_011519666.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CHSY1ENST00000254190.4 linkc.333G>A p.Lys111Lys synonymous_variant Exon 2 of 3 1 NM_014918.5 ENSP00000254190.3 Q86X52
CHSY1ENST00000559384.1 linkn.83G>A non_coding_transcript_exon_variant Exon 2 of 2 3

Frequencies

GnomAD3 genomes
AF:
0.00538
AC:
818
AN:
152042
Hom.:
6
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00109
Gnomad AMI
AF:
0.00220
Gnomad AMR
AF:
0.0291
Gnomad ASJ
AF:
0.00202
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00290
Gnomad FIN
AF:
0.000662
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00420
Gnomad OTH
AF:
0.00622
GnomAD2 exomes
AF:
0.00977
AC:
2420
AN:
247778
AF XY:
0.00812
show subpopulations
Gnomad AFR exome
AF:
0.000687
Gnomad AMR exome
AF:
0.0528
Gnomad ASJ exome
AF:
0.00129
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.000530
Gnomad NFE exome
AF:
0.00397
Gnomad OTH exome
AF:
0.00559
GnomAD4 exome
AF:
0.00541
AC:
7895
AN:
1458008
Hom.:
86
Cov.:
32
AF XY:
0.00517
AC XY:
3749
AN XY:
725530
show subpopulations
African (AFR)
AF:
0.000657
AC:
22
AN:
33480
American (AMR)
AF:
0.0499
AC:
2231
AN:
44720
Ashkenazi Jewish (ASJ)
AF:
0.00111
AC:
29
AN:
26136
East Asian (EAS)
AF:
0.0000252
AC:
1
AN:
39700
South Asian (SAS)
AF:
0.00243
AC:
210
AN:
86250
European-Finnish (FIN)
AF:
0.000584
AC:
29
AN:
49686
Middle Eastern (MID)
AF:
0.00121
AC:
7
AN:
5768
European-Non Finnish (NFE)
AF:
0.00457
AC:
5080
AN:
1111900
Other (OTH)
AF:
0.00474
AC:
286
AN:
60368
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.459
Heterozygous variant carriers
0
402
804
1207
1609
2011
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
230
460
690
920
1150
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00540
AC:
822
AN:
152160
Hom.:
8
Cov.:
32
AF XY:
0.00565
AC XY:
420
AN XY:
74366
show subpopulations
African (AFR)
AF:
0.00108
AC:
45
AN:
41514
American (AMR)
AF:
0.0293
AC:
447
AN:
15266
Ashkenazi Jewish (ASJ)
AF:
0.00202
AC:
7
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5172
South Asian (SAS)
AF:
0.00311
AC:
15
AN:
4818
European-Finnish (FIN)
AF:
0.000662
AC:
7
AN:
10574
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00420
AC:
286
AN:
68028
Other (OTH)
AF:
0.00616
AC:
13
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
43
86
130
173
216
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00332
Hom.:
2
Bravo
AF:
0.00720
Asia WGS
AF:
0.00115
AC:
4
AN:
3478
EpiCase
AF:
0.00453
EpiControl
AF:
0.00385

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
Feb 20, 2019
Athena Diagnostics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Nov 27, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Temtamy preaxial brachydactyly syndrome Benign:2
Mar 28, 2022
Fulgent Genetics, Fulgent Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 20, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.39
CADD
Benign
14
DANN
Benign
0.66
PhyloP100
0.85
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.020
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs117481449; hg19: chr15-101775770; COSMIC: COSV54252749; COSMIC: COSV54252749; API